Serious Baseball

2/04/2005

The Magglio Ordonez Show

As the off season dwindles down towards the beginning of spring training almost all big-name free agents have been signed by one team or another. All except one, Magglio Ordonez.

For those of you unaware of who Magglio Ordonez is, he was the Chicago White Sox starting right fielder for the past 7 seasons (had been with White Sox for 8 seasons total). For those seven years Ordonez was, undoubtedly, baseball’s best kept secret. While getting very little publicity and fanfare, here are Ordonez's statistics through his career up to this point:

3807 AB, 1167 H, 240 2B, 15 3B, 187 HR, 703 RBI, 82 SB, 38 CS, 333 BB, 431 K, 34 HBP, 35 SF

.307 AVG/.364 OBP/.525 SLG--.889 OPS

***See Magglio Ordonez Stat Profile at Baseball Prospectus:

http://www.baseballprospectus.com/dt/ordonma01.shtml***


That, my friends, is a superstar.

With Ordonez having just turned 31 years old on January 28, he still has, at least, a few dominant years left in him.

At least those were the beliefs before May 24, 2004 when Ordonez suffered a severe knee and calf injury, which made him miss most of the remainder of the 2004 season.

At first the injury was believed to be one that was so bad that he could also miss some of the 2005 season. Later though, it has since been rumored that Ordonez fully healed some time in the month of December.

As you can tell, those two beliefs are polar opposites of one another, which is the main reason Ordonez isn’t already signed by a team. With the statistics he put up before the injury, he was worth top-dollar--no question.

My, oh my, how things change.

Even though it seems some teams are starting to believe that Ordonez is fully healthy, as shown by the 5 year/$55 million deal reportedly offered to him by the Detroit Tigers; it is obvious that Ordonez is a huge injury-risk for 2005 and beyond.

As much as Ordonez’s agent, Scott Boras, will try to have everybody believe his client is fully healthy and ready-to-go, it cannot be overlooked that a player of Ordonez’s quality is still unsigned in February.

If there were a “mid-level” risk involved with Ordonez’s injury problem, some team out there would have snatched him up quicker than you and say “Home Run by Ordonez.” But there haven’t been any suitors.

Now I don’t know about you, but that tells me something:

Ordonez is "high-level" risk.

With that, I wish the best of luck to whomever signs this superstar with bad timing.


Thank you for reading.

Frank Bundy III

If you have any questions, comments, concerns, or suggestions, please do not hesitate to email me at frnkbndy@yahoo.com.

Also, check out Serious Baseball at AtHomePlate.com, a baseball column authored by me, and my colleague, Matthew Souders.







3 Comments:

  • Big News From The Healthcare Industry!!

    +++++++++++Current Profile+++++++++++
    Faceprint Global Solutions (FCPG)
    Current Price $0.15
    A company with hot new identity solution products
    and licenses with over 40 current governmental and
    non-governmental contracts in negotiations.
    +++++++++++++++++++++++++++++++++

    Is this an undiscovered gem priced to go higher!!
    Please read the following Announcement in its Entirety and Consider the Possibilities�
    Watch this One to Trade!

    FCPG volume trading is beginning to surge with this landslide Announcement. The value of this
    stock appears poised for growth! This one should not remain on the ground floor for long.

    BREAKING NEWS!!

    Faceprint Global Solutions (FCPG) is pleased to announce that its European partner, Keyvelop, has teamed up with IBM's Partner World Industry Networks to deliver customer software requirement solutions for the international healthcare industry.
    With FGS owning the exclusive North American rights to distribute the worlds leading encryption and transmission software developed by Keyvelop, FGS is poised to capture large volumes of sales generated by customers currently using IBM's software in the healthcare and other industries.
    With traceability and security now deemed a serious business priority, companies are increasingly focused on employing procedures and controls designed to ensure the authenticity, integrity and confidentiality of electronic records.
    "This is a very positive move for FGS and for Keyvelop," said FGS CEO Pierre Cote. "We are very happy about the decision to go with IBM. This is a continuation of the progress made by everyone associated with FGS and its partners."
    Buell Duncan, IBM's general manager of ISV & Developer Relations commented, "Collaborating with Keyvelop will ensure that we develop open solutions that are easy to maintain and cost effective for our customers in the healthcare and life sciences industry."
    Among other things, this new software technology which is currently being used by a number of European healthcare companies, is used to send any file, regardless of format or size. Encryption keys, evidence of transmission integrity with fingerprint calculation, time-stamping of all actions and status record updating, pre-checking sender and receiver identities, validating file opening dates are part of Keyvelop features.
    About FacePrint Global Solutions, Inc.
    FGS operates a business, which develops and delivers a variety of technology solutions, including biometric software applications on smart cards and other support mediums (apometric solutions). FGS's products provide biometric solutions for identity authentication and a host of smart card- and biometrics-related hardware peripherals and software applications. Apometrix, FGS's wholly-owned subsidiary, combines on-card or in-chip multi-application management solutions with best-of-breed 'in-card matching' biometrics. Keyvelop's secure digital envelope solution and Apometrix's on-card biometrics work together to produce the winning combination in the fields of security, traceability and identity management. FGS is headquartered in Fresno, California.
    Conclusion:

    The examples above show the Awesome, Earning Potential of little known Companies That Explode onto Investor's Radar Screens. This stock will not be a Secret for long. Then You May Feel the Desire to Act Right Now! And Please Watch This One Trade!
    GO FCPG!

    All statements made are our express opinion only and should be treated as such. We may own, take position and sell any securities mentioned at any time. Any statements that express or involve discussions with respect to predictions, goals, expectations, beliefs, plans, projections, objectives, assumptions or future events or performance are not statements of historical fact and may be "forward looking statements." Forward looking statements are based on expectations, estimates and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. This profile is in no way affiliated with the featured company. We were compensated one thousand dollars from third party (IR Marketing) to distribute this report. Forward looking statements in this action may be identified through the use of words such as: "projects", "foresee", "expects". in compliance with Section 17(b), we disclose the holding of FGS shares prior to the publication of this report. Be aware of an inherent conflict of interest resulting from such holdings due to our intent to profit from the liquidation of these shares. Shares may be sold at any time, even after positive statements have been made regarding the above company. Since we own shares, there is an inherent conflict of interest in our statements and opinions. Readers of this publication are cautioned not to place undue reliance on forward-looking statements, which are based on certain assumptions and expectations involving various risks and uncertainties that could cause results to differ materially from those set forth in the forward- looking statements. This is not solicitation to buy or sell stocks, this text is for informational purpose only and you should seek professional advice from registered financial advisor before you do anything related with buying or selling stocks, penny stocks are very high risk and you can lose your entire investment.

    By Blogger lqsp53phfg, at 4:16 AM  

  • This comment has been removed by a blog administrator.

    By Blogger Roberto Iza Valdes, at 7:33 AM  

  • Your site BaseballFan, I found to be very interesting. When I was searching for 408 yours was the most eyecatching. While working on my site 408 I have been seeking ways to make it better and found yours to be helpful. Thanks!

    By Blogger jim, at 6:35 AM  

Post a Comment

<< Home